Literature DB >> 9073394

PDGF-alpha receptor and myelin basic protein mRNAs are not coexpressed by oligodendrocytes in vivo: a double in situ hybridization study in the anterior medullary velum of the neonatal rat.

A M Butt1, M F Hornby, M Ibrahim, S Kirvell, A Graham, M Berry.   

Abstract

Platelet-derived growth factor (PDGF) is a growth-regulatory dimer with A and B subunits. PDGF-AA, acting via PDGF receptors of the alpha-unit subtype (PDGF-alphaR), is implicated in the differentiation of oligodendrocyte precursors and in the survival of newly formed oligodendrocytes, which gradually lose expression of PDGF-alphaR. However, it is unclear whether terminally differentiated oligodendrocytes express PDGF-alphaR in vivo. To address this question, and to help clarify the role of PDGF-AA in late oligodendrocyte differentiation, we have used double in situ hybridization with digoxigenin- and fluorescein-labeled riboprobes to relate PDGF-alphaR mRNA and myelin basic protein (MBP) mRNA expression in the isolated intact anterior medullary velum (AMV) of rats ages Postnatal Day (P) 10-12 and P30-32. In parallel experiments, AMV were immunolabeled with the oligodendrocyte-specific monoclonal antibody Rip to provide information on oligodendrocyte development and the extent of myelination. At P10, the AMV contained tracts in which axons ranged from unmyelinated to fully myelinated, whereas myelination was complete in P30-32 AMV. The first oligodendrocytes to express MBP mRNA or Rip were promyelinating oligodendrocytes, which had a "star-burst" morphology and had not yet begun to form myelin sheaths. As myelination proceeded, MBP mRNA became dispersed throughout oligodendrocyte units, comprising cell somata, processes, and internodal myelin sheaths. By P30-32, MBP mRNA had been redistributed to the myelin sheaths only, reflecting a change in the site of protein synthesis in mature myelinated axon tracts. At no stage of oligodendrocyte differentiation did we observe cellular coexpression of mRNA for PDGFalphaR and MBP. Our results indicated that oligodendrocytes lost the expression of PDGFalphaR prior to gaining that of myelin gene products, and preclude an action of PDGF-AA on Rip+/MBP+ star-burst promyelinating oligodendrocytes. The spatial and temporal expression of PDGF-alphaR mRNA in the AMV was inversely related to the pattern of maturation of both myelin and oligodendrocytes, and is consistent with PDGF-alphaR being expressed by pro-oligodendrocytes. A notable finding was the high level of expression of PDGF-alphaR mRNA in the AMV of juvenile rats, localized to cell bodies within the myelinated axon tracts, strongly suggesting that oligodendrocyte precursors persisted in the mature velum.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9073394     DOI: 10.1006/mcne.1996.0590

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  10 in total

1.  Expression of mutant human DISC1 in mice supports abnormalities in differentiation of oligodendrocytes.

Authors:  Pavel Katsel; Weilun Tan; Bagrat Abazyan; Kenneth L Davis; Christopher Ross; Mikhail V Pletnikov; Vahram Haroutunian
Journal:  Schizophr Res       Date:  2011-05-24       Impact factor: 4.939

2.  Sox10 is necessary for oligodendrocyte survival following axon wrapping.

Authors:  Norio Takada; Sarah Kucenas; Bruce Appel
Journal:  Glia       Date:  2010-06       Impact factor: 7.452

3.  Dysfunction of platelet-derived growth factor receptor α (PDGFRα) represses the production of oligodendrocytes from arylsulfatase A-deficient multipotential neural precursor cells.

Authors:  Katarzyna C Pituch; Ana L Moyano; Aurora Lopez-Rosas; Felecia M Marottoli; Guannan Li; Chenqi Hu; Richard van Breemen; Jan E Månsson; Maria I Givogri
Journal:  J Biol Chem       Date:  2015-01-20       Impact factor: 5.157

4.  Bisphenol-A impairs myelination potential during development in the hippocampus of the rat brain.

Authors:  Shashi Kant Tiwari; Swati Agarwal; Lalit Kumar Singh Chauhan; Vijay Nath Mishra; Rajnish Kumar Chaturvedi
Journal:  Mol Neurobiol       Date:  2014-08-02       Impact factor: 5.590

5.  Bone marrow stromal cell transdifferentiation into oligodendrocyte-like cells using triiodothyronine as a inducer with expression of platelet-derived growth factor α as a maturity marker.

Authors:  Hojjat-Allah Abbaszadeh; Taki Tiraihi; Ali Reza Delshad; Majid Saghedi Zadeh; Taher Taheri
Journal:  Iran Biomed J       Date:  2013-04

6.  NG2 glia generate new oligodendrocytes but few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease.

Authors:  Richa B Tripathi; Leanne E Rivers; Kaylene M Young; Francoise Jamen; William D Richardson
Journal:  J Neurosci       Date:  2010-12-01       Impact factor: 6.167

7.  Prenatal overexpression of platelet-derived growth factor receptor A results in central nervous system hypomyelination.

Authors:  Herminio Joey Cardona; Agila Somasundaram; Donna M Crabtree; Samantha L Gadd; Oren J Becher
Journal:  Brain Behav       Date:  2021-09-04       Impact factor: 2.708

8.  PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice.

Authors:  Leanne E Rivers; Kaylene M Young; Matteo Rizzi; Françoise Jamen; Konstantina Psachoulia; Anna Wade; Nicoletta Kessaris; William D Richardson
Journal:  Nat Neurosci       Date:  2008-10-08       Impact factor: 24.884

9.  Expression of oligodendroglial differentiation markers in pilocytic astrocytomas identifies two clinical subsets and shows a significant correlation with proliferation index and progression free survival.

Authors:  Hidehiro Takei; Subashini T Yogeswaren; Kwong-Kwok Wong; Vidya Mehta; Murali Chintagumpala; Robert C Dauser; Ching C Lau; Adekunle M Adesina
Journal:  J Neurooncol       Date:  2007-08-10       Impact factor: 4.506

10.  CSF and Brain Indices of Insulin Resistance, Oxidative Stress and Neuro-Inflammation in Early versus Late Alzheimer's Disease.

Authors:  Sarah Lee; Ming Tong; Steven Hang; Chetram Deochand; Suzanne de la Monte
Journal:  J Alzheimers Dis Parkinsonism       Date:  2013-10-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.